NCT Number: NCT05767138
STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012
Although screening for pre-cancerous cervical lesions and human papilloma virus (HPV) vaccination are accepted and effective means to prevent cervical cancer, women in Mali have limited access to these interventions. In addition, cervical cancer prevention by HPV vaccination has been controversial in some settings. To reduce cervical cancer prevalence and increase HPV vaccine uptake, it is important to understand the level of knowledge about cervical cancer screening and practices related to vaccination in at-risk populations. In this study, the level of knowledge about HPV and cervical cancer and attitudes towards vaccination were assessed among 301 participants (male and female, adults and adolescents) in a house-to-house survey in two urban neighborhoods in Bamako, Mali. The survey was combined with a brief educational session on HPV. Prior to the education session, overall knowledge of HPV infection and cervical cancer was very low: only 8% knew that HPV is a sexually transmitted infection (STI). Less than 20% of women had ever consulted a gynecologist and less than 3% had ever had cervical cancer screening. After hearing a description of HPV vaccine, more than 80% would accept HPV vaccination; fathers and husbands were identified as primary decisions makers and local clinics or the home as preferred sites for vaccination. This study provides information on STI knowledge and vaccine acceptance in Bamako, Mali in 2012, prior to the introduction of HPV vaccination.
Looking for future studies?
Notify MeKey information
Conditions
Age range
12 year and older
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 12-17 years of age, with guardian consent
- 18 years or older
- Male or Female
- Living in Mèkin-Sikoro and Djikoroni
Exclusion criteria
- 12-17 years of age, without guardian consent
- <12 years of age
- Living outside Mèkin-Sikoro and Djikoroni
Treatment and study plan
Primary outcomes
-
Participants' acceptance of the vaccine
Time frame: immediately after the intervention
Number of participants willing to be vaccinated against HPV and their vaccination preferences after educational sessions
Secondary outcomes
-
Knowledge of STIs, HPV, and Cervical Cancer
Time frame: immediately after the intervention
Knowledge Question asked before and after educational session
Sponsors and collaborators
Lead sponsor
Global Alliance to Immunize Against AIDS Vaccine Foundation
Other
Collaborators
- Merck Sharp & Dohme LLC
Registry information
Official study title
Knowledge, Attitudes, Practices and Willingness to Vaccinate in Preparation for the Introduction of HPV Vaccines in Bamako, Mali
Important dates
- Study start
- 2011
- Primary completion
- 2011
- Study completion
- 2011
- First posted
- Mar 14, 2023
- Registry last updated
- Mar 14, 2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
NCT04722822
HPV
Los Angeles, California, United States
View Trial DetailsAcceptability of the HPV Vaccine and Anal HPV in Transgender Women and Men Who Have Sex With Men: A Pilot Study
NCT06588257
HPV
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
View Trial DetailsCervical Thermal Ablation to Treat Persistent HPV Infection
NCT07376031
Cervical Cancer Screening, HPV
Hvidovre, Denmark
View Trial DetailsActions For Collaborative Community Engaged Strategies for HPV
NCT06010108
Behavior, HPV
Yaba, Lagos, Nigeria
View Trial Details